Professor Ranjit Manchanda Professor of Gynaecological Oncology & Consultant Gynaecological Oncologist; Co-Lead, Cancer Prevention UnitEmail: r.manchanda@qmul.ac.ukRoom Number: Room 131, Wolfson InstituteProfilePublicationsSupervisionProfileI was appointed as Professor of Gynaecological Oncology at Wolfson Institute of Population Health, QMUL in Sep 2019. I worked at Barts Cancer Institute, QMUL as a Clinical Senior Lecturer from June 2015. I have worked as a consultant Gynaecological Oncologist at Barts Health NHS Trust from June 2015. From 2014- 2015 I worked as a Locum Consultant Gynaecological Oncologist at Barts Health and Honorary Senior Lecturer at University College London, UK. I completed a PhD in gynaecological oncology at UCL, followed by a NIHR ACL Fellowship and subspecialty training in gynaecological oncology from UCLH and Bart's Hospital. Research: My research is focused on Targeted Precision Prevention. This includes population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, population stratification, targeted screening, cancer prevention (including surgical) and management of familial gynaecological cancer. I have a keen research interest in health economic issues related to these areas. I am Chief Investigator (CI) on PROTECT (PROTECT: Population based Germline testing for Early detection and Cancer Prevention); PROTECTOR (Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal) trial; DETECT-2 (Direct to Patient testing at Cancer diagnosis for Precision Prevention) study; PROMISE Feasibility study (pilot general population testing and personalised ovarian cancer risk prediction study); SIGNPOST (SystematIc GeNetic testing for Personalised Ovarian cancer Therapy) study and RRESDO (study evaluating attitudes towards early salpingectomy) studies; Co-PI of GCaPPS trial (population based BRCA testing RCT in the Jewish population); Co-Lead for UKCOGS (UK COVID and Gynaecological Cancer Study); Co-lead for SURAKSHA- South Asian Breast Cancer Risk Prediction, Genetic testing & Health Management programme. I have worked on ovarian cancer screening trials (UKCTOCS, UKFOCSS and ALDO).ResearchPublications Philpott S, Raikou M, Manchanda R et al. (2023). The avoiding late diagnosis of ovarian cancer (ALDO) project; A pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2. nameOfConference DOI: 10.1136/jmg-2022-108741 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82478 Laforêts F, Kotantaki P, Malacrida B et al. (2023). Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments. nameOfConference DOI: 10.1016/j.isci.2023.106514 QMRO: qmroHref Elorbany S, Berlato C, Carnevalli L et al. (2023). Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer. nameOfConference DOI: 10.1158/1538-7445.am2023-lb195 QMRO: qmroHref Malacrida B, Elorbany S, Maniati E et al. (2023). Abstract 4551: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer: understanding the contribution of malignant cells. nameOfConference DOI: 10.1158/1538-7445.am2023-4551 QMRO: qmroHref Laforets F, Kotantaki P, Malacrida B et al. (2023). Abstract 5913: Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments. nameOfConference DOI: 10.1158/1538-7445.am2023-5913 QMRO: qmroHref Kotantaki P, Laforêts F, Maniati E et al. (2023). Abstract 5957: Chemotherapy-induced extracellular matrix remodeling in HGSOC. nameOfConference DOI: 10.1158/1538-7445.am2023-5957 QMRO: qmroHref Lacaze P, Manchanda R, Green RC (2023). Prioritizing the detection of rare pathogenic variants in population screening. nameOfConference DOI: 10.1038/s41576-022-00571-9 QMRO: qmroHref Gaba F, Blyuss O, Tan A et al. (2023). Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. nameOfConference DOI: 10.3390/cancers15051625 QMRO: qmroHref Oxley S, Wei X, Sideris M et al. (2023). Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer. nameOfConference DOI: 10.1007/978-981-19-7630-8_8 QMRO: qmroHref Oxley S, Kalra A, Sideris M et al. (2023). Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK. nameOfConference DOI: 10.3390/cancers15041273 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84629 Bizzarri N, Dostálek L, Van Lonkhuijzen LRCW et al. (2023). Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy. nameOfConference DOI: 10.1097/AOG.0000000000005026 QMRO: qmroHref Morgan RD, Clamp AR, Barnes BM et al. (2023). Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: A multi-national observational study. nameOfConference DOI: 10.1136/ijgc-2022-004211 QMRO: qmroHref Wei X, Oxley S, Sideris M et al. (2023). Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis. nameOfConference DOI: 10.1016/j.ajog.2023.03.045 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85819 Yong N, Cooper N, Yorke S et al. (2023). Variation in outcome reporting in studies of fertility-sparing surgery for cervical cancer: A systematic review. nameOfConference DOI: 10.1111/1471-0528.17342 QMRO: qmroHref Wei X, Oxley S, Sideris M et al. (2022). Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review. nameOfConference DOI: 10.3390/cancers14246117 QMRO: qmroHref Oxley S, Xiong R, Wei X et al. (2022). Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review. nameOfConference DOI: 10.3390/cancers14235832 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83022 Hanson H, Kulkarni A, Loong L et al. (2022). UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. nameOfConference DOI: 10.1136/jmg-2022-108898 QMRO: qmroHref Gaba F, Ash K, Blyuss O et al. (2022). Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative). nameOfConference DOI: 10.1136/ijgc-2022-004101 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82509 Wei X, Oxley S, Sideris M et al. (2022). 2022-RA-1270-ESGO Quality of Life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2022-esgo.822 QMRO: qmroHref Wei X, Oxley S, Sideris M et al. (2022). 2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2022-esgo.823 QMRO: qmroHref Gaba F, Blyuss O, Tan A et al. (2022). 2022-RA-1390-ESGO Meta-analysis of breast cancer risk and breast cancer specific mortality following risk reducing salpingo-oophorectomy in BRCA carriers. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2022-esgo.825 QMRO: qmroHref Yong N, Cooper N, Yorke S et al. (2022). 2022-RA-1407-ESGO Variation in outcome reporting in studies of fertility sparing surgery for cervical cancer: a systematic review. Fertility/Pregnancy DOI: 10.1136/ijgc-2022-esgo.384 QMRO: qmroHref Sobocan M, Chandrasekaran D, Sideris M et al. (2022). 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer. Vaginal and vulvar cancer DOI: 10.1136/ijgc-2022-esgo.1000 QMRO: qmroHref Burnell M, Gaba F, Sideris M et al. (2022). 2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes. Quality of life after treatment DOI: 10.1136/ijgc-2022-esgo.861 QMRO: qmroHref Van der Kolk WL, Van der Zee AGJ, Slomovitz BM et al. (2022). Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. nameOfConference DOI: 10.1016/j.ygyno.2022.07.017 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82483 Cummins C, Kumar S, Long J et al. (2022). Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study. nameOfConference DOI: 10.3390/cancers14184362 QMRO: qmroHref Sun L, Wei X, Manchanda R et al. (2022). Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control. nameOfConference DOI: 10.46234/ccdcw2022.148 QMRO: qmroHref Manchanda R, Sideris M (2022). Population based genetic testing for cancer susceptibility genes: quo vadis. nameOfConference DOI: 10.1111/1471-0528.17283 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80204 Torr B, Jones C, Choi S et al. (2022). A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot. nameOfConference DOI: 10.1136/jmg-2022-108655 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79662 Burnell M, Gaba F, Sobocan M et al. (2022). Randomised trial of population based BRCA testing in Ashkenazi Jews: Long term secondary lifestyle behavioural outcomes. nameOfConference DOI: 10.1111/1471-0528.17253 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79318 Lee A, Yang X, Tyrer J et al. (2022). Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors. nameOfConference DOI: 10.1136/jmedgenet-2021-107904 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72638 Tindale LC, Zhantuyakova A, Lam S et al. (2022). Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. nameOfConference DOI: 10.3390/curroncol29070368 QMRO: qmroHref Sundar S, Cummins C, Kumar S et al. (2022). Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study. nameOfConference DOI: 10.1111/1471-0528.17041 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75658 Barrett JE, Jones A, Evans I et al. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. nameOfConference DOI: 10.1038/s41467-021-26615-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76607 Kalra A, Sobocan M, Reisel D et al. (2022). Role of Genetics in Gynaecological Cancers. nameOfConference DOI: 10.1007/978-3-030-94110-9_17 QMRO: qmroHref Reisel D, Burnell M, Side L et al. (2022). Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study. nameOfConference DOI: 10.1111/1471-0528.16994 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75198 Gaba F, Oxley S, Liu X et al. (2022). Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews. nameOfConference DOI: 10.3390/diagnostics12051028 QMRO: qmroHref Sun L, Cui B, Wei X et al. (2022). Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China. nameOfConference DOI: 10.3390/cancers14071839 QMRO: qmroHref Taylor A, Sundar SS, Bowen R et al. (2022). British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic. nameOfConference DOI: 10.1097/01.ogx.0000822432.56370.10 QMRO: qmroHref Taylor A, Sundar SS, Bowen R et al. (2022). British Gynaecological Cancer Society Recommendations for Women with Gynecological Cancer Who Received Non-standard Care during the COVID-19 Pandemic. nameOfConference DOI: 10.1097/01.ogx.0000822432.56370.10 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75383 Cibula D, Dostálek L, Jarkovsky J et al. (2022). Post-recurrence survival in patients with cervical cancer. nameOfConference DOI: 10.1016/j.ygyno.2021.12.018 QMRO: qmroHref Gaba F, Goyal S, Marks D et al. (2022). Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: A qualitative study. nameOfConference DOI: 10.1136/jmedgenet-2020-107501 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69243 Manchanda R (2022). Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer. nameOfConference DOI: 10.3390/books978-3-0365-2983-7 QMRO: qmroHref Taylor JA, Burnell M, Ryan A et al. (2022). Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. nameOfConference DOI: 10.1111/1471-0528.16943 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74278 Kriplani D, Olivar AA, Tchrakian N et al. (2022). Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting.. nameOfConference DOI: 10.1097/PGP.0000000000000761 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67879 Manchanda R, Gaba F, Talaulikar V et al. (2022). Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66. nameOfConference DOI: 10.1111/1471-0528.16896 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74884 Manchanda R (2022). Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”. nameOfConference DOI: 10.3390/cancers14020319 QMRO: qmroHref Philpott S, Raikou M, Manchanda R et al. (2021). 423 Results of the avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance program for BRCA mutation-carriers. nameOfConference DOI: 10.1136/ijgc-2021-esgo.661 QMRO: qmroHref Manchanda R, Oxley S, Ghaem-Maghami S et al. (2021). COVID-19 and the impact on gynecologic cancer care. nameOfConference DOI: 10.1002/ijgo.13868 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73649 Cibula D, Dostálek L, Jarkovsky J et al. (2021). The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. nameOfConference DOI: 10.1016/j.ejca.2021.09.008 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74692 Sundar S, Cummins C, Balega J et al. (2021). 718 Investigating impact of ultra-radical surgery in advanced ovarian cancer using population level data linked to the SOCQER 2 multicentre study. Ovarian cancer DOI: 10.1136/ijgc-2021-esgo.452 QMRO: qmroHref Reisel D, Burnell M, Side L et al. (2021). 874 Uptake of population based BRCA-testing across Jewish denominations and affect of cultural and religious factors: a cohort study. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2021-esgo.557 QMRO: qmroHref Van Lonkhuijzen L, Dostalek L, Jarkovsky J et al. (2021). 942 Survival after recurrence in early-stage cervical cancer patients. Cervical cancer DOI: 10.1136/ijgc-2021-esgo.78 QMRO: qmroHref Cibula D, Jarkovsky J, Van Lonkhuijzen L et al. (2021). 960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients. Cervical cancer DOI: 10.1136/ijgc-2021-esgo.82 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74887 Gaba F, Blyuss O, Rodriguez I et al. (2021). 984 Impact of SARS-CoV-2 on training and mental wellbeing of surgical gynaecological oncology trainees. Miscellaneous DOI: 10.1136/ijgc-2021-esgo.284 QMRO: qmroHref Rockall AG, Barwick TD, Wilson W et al. (publicationYear). DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA. nameOfConference DOI: 10.1158/1078-0432.ccr-21-1834 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74146 Gaba F, Blyuss O, Rodriguez I et al. (2021). Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees.. nameOfConference DOI: 10.1136/ijgc-2021-002803 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73179 Chandrasekaran D, Sobocan M, Blyuss O et al. (2021). Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: Signpost study. nameOfConference DOI: 10.3390/cancers13174344 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74102 Menon U, Gentry-Maharaj A, Burnell M et al. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial. nameOfConference DOI: 10.1097/01.ogx.0000792624.55995.3e QMRO: qmroHref Reisel D, Baran C, Manchanda R (publicationYear). Preventive population genomics- the model of BRCA related cancers. nameOfConference DOI: 10.1016/bs.adgen.2021.08.001 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73806 Oonk MH, Slomovitz B, Baldwin P et al. (2021). Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II.. nameOfConference DOI: 10.1200/JCO.21.00006 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73180 Mariño IP, Vázquez MA, Blyuss O et al. (2021). Computational learning methods for early detection of ovarian cancer. Emerging Topics in Artificial Intelligence (ETAI) 2021 DOI: 10.1117/12.2594225 QMRO: qmroHref Menon U, Gentry-Maharaj A, Burnell M et al. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. nameOfConference DOI: 10.1016/S0140-6736(21)00731-5 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71892 Phadnis S, Selek S, Farrag A et al. (2021). Cytoreduction surgery for recurrent ovarian cancer: cohort study from UK tertiary centre. nameOfConference DOI: doi QMRO: qmroHref Cohen PA, Powell A, Böhm S et al. (2021). Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448 (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679)). nameOfConference DOI: 10.1016/j.ygyno.2021.01.032 QMRO: qmroHref Gaba F, Blyuss O, Chandrasekaran D et al. (2021). Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study. nameOfConference DOI: 10.1111/1471-0528.16424 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66501 Sundar S, Manchanda R, Gourley C et al. (2021). British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.. nameOfConference DOI: 10.1136/ijgc-2020-002112 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69786 Gaba F, Robbani S, Singh N et al. (2021). Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): Protocol for a prospective non-randomised multi-center trial. nameOfConference DOI: 10.1136/ijgc-2020-001541 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67159 Gaba F, Blyuss O, Sanderson S et al. (2020). 401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2020-esgo.159 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69723 Gaba F, Blyuss O, Legood R et al. (2020). 505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2020-esgo.160 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69595 Gaba F, Marks D, Saridogan E et al. (2020). 507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study. Prevention of gynaecologic cancer DOI: 10.1136/ijgc-2020-esgo.161 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69593 Gallagher A, Waller J, Manchanda R et al. (2020). Women’s intentions to engage in risk-reducing behaviours after receiving personal ovarian cancer risk information: An experimental survey study. nameOfConference DOI: 10.3390/cancers12123543 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68879 Krämer P, Grube M, Renno T et al. (2020). 454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD). Poster DOI: 10.1136/ijgc-2020-igcs.394 QMRO: qmroHref Krämer P, Talhouk A, Brett MA et al. (2020). Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma. nameOfConference DOI: 10.1158/1078-0432.CCR-20-1268 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66346 Grube M, Krämer P, Chiu D et al. (2020). Immunhistochemische Expression von L1CAM in endometrioiden Ovarialkarzinomen – Ein neuer prognostischer Marker?. Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) DOI: 10.1055/s-0040-1718139 QMRO: qmroHref Manchanda R, Lieberman S, Gaba F et al. (2020). Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. nameOfConference DOI: 10.1146/annurev-genom-083118-015253 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68523 Evans O, Manchanda R (2020). Population-based genetic testing for precision prevention. nameOfConference DOI: 10.1158/1940-6207.CAPR-20-0002 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65425 Manchanda R, Sun L, Patel S et al. (2020). Economic evaluation of population-based brca1/brca2 mutation testing across multiple countries and health systems. nameOfConference DOI: 10.3390/cancers12071929 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68194 Gentry-Maharaj A, Blyuss O, Ryan A et al. (2020). Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women. nameOfConference DOI: 10.3390/cancers12071931 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68195 Gaba F, Blyuss O, Liu X et al. (2020). Population study of ovarian cancer risk prediction for targeted screening and prevention. nameOfConference DOI: 10.3390/cancers12051241 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64757 Cohen PA, Powell A, Böhm S et al. (2020). Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448] (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679)). nameOfConference DOI: 10.1016/j.ygyno.2020.02.023 QMRO: qmroHref Manchanda R, Buist DSM, Evans DGR (2020). Future Research Suggestions for Multigene Testing in Unselected Populations-Reply. nameOfConference DOI: 10.1001/jamaoncol.2020.0131 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65657 Evans O, Gaba F, Manchanda R (2020). Population-based genetic testing for Women's cancer prevention. nameOfConference DOI: 10.1016/j.bpobgyn.2020.02.007 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64715 Manchanda R (2020). Advances in the screening and prevention of Women's cancers. nameOfConference DOI: 10.1016/j.bpobgyn.2020.03.008 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64691 Casey L, Powell A, Bohm S et al. (2020). Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68674 Gaba F, Manchanda R (2020). Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers. nameOfConference DOI: 10.1016/j.bpobgyn.2020.01.006 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66571 Manchanda R, Burnell M, Gaba F et al. (2020). Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. nameOfConference DOI: 10.1111/1471-0528.15905 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60978 Ryan N, Wall J, Crosbie EJ et al. (2019). Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results. nameOfConference DOI: 10.1111/his.13925 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60981 Gaba F, Chandrasekaran D, Menon U et al. (2019). EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study. ePoster Talks: Ovarian + Endometria DOI: 10.1136/ijgc-2019-esgo.63 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66640 Gaba F, Liu X, Chandrasekaran D et al. (2019). EP1231 Impact of population genetic testing and ovarian cancer risk stratification on the emotional well-being and health of unselected women in a general population. ePoster Talks: Ovarian + Endometria DOI: 10.1136/ijgc-2019-esgo.65 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65700 Sundar S, Cummins C, Kumar S et al. (2019). EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study. ePoster DOI: 10.1136/ijgc-2019-esgo.1275 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66598 Daia M, Chandrasekaran D, Lawrence A et al. (2019). EP1332 Follow the yellow brick road – Supra-renal para-aortic lymphadenectomy for metastatic ovarian cancer. Cinema Viewing DOI: 10.1136/ijgc-2019-esgo.1336 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65649 Gaba F, Farrag A, Lawrence A et al. (2019). EP1342 Ovarian cancer with metastatic inguinal lymphadenopathy: an abdominal approach to inguinal nodes dissection. Cinema Viewing DOI: 10.1136/ijgc-2019-esgo.1346 QMRO: qmroHref Dokmeci A, Abdurrayman M, Drymiotou S et al. (2019). EP507 Has the robot been beneficial to endometrial cancer patients? A prospective quality improvement project at a london gynae-oncology tertiary centre. ePoster DOI: 10.1136/ijgc-2019-esgo.565 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65682 Drymiotou S, Dokmeci A, Chandrasekaran D et al. (2019). EP510 Robotic surgery: does high body mass index (BMI) matter?. ePoster DOI: 10.1136/ijgc-2019-esgo.568 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67592 Manchanda R, Burnell M, Gaba F et al. (2019). Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing. Best Oral/Late-Breaking Abstracts 4 – Miscellaneous DOI: 10.1136/ijgc-2019-esgo.15 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66610 Sun L, Brentnall A, Patel S et al. (2019). Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. Oral Communication 4 – Gynaecological Cancer DOI: 10.1136/ijgc-2019-esgo.31 QMRO: qmroHref Sun L, Brentnall A, Patel S et al. (publicationYear). A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer. nameOfConference DOI: 10.1001/jamaoncol.2019.3323 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64584 Manchanda R, Sun L, Patel S et al. (2019). 10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing. Plenary sessions DOI: 10.1136/ijgc-2019-igcs.10 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63059 Sun L, Brentnall A, Patel S et al. (2019). 66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. nameOfConference DOI: 10.1136/ijgc-2019-igcs.66 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65196 Manchanda R, Burnell M, Gaba F et al. (2019). 81 Attitude towards and factors affecting uptake of population based BRCA testing in ashkenazi jews: a cohort study. E-Poster discussions DOI: 10.1136/ijgc-2019-igcs.81 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62727 Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). RCOG World Congress 2019 DOI: 10.1111/1471-0528.6_15703 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62201 Tan A, Rivas C, Yorke S et al. (2019). Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets). nameOfConference DOI: doi QMRO: qmroHref Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62203 Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62202 Cohen PA, Powell A, Böhm S et al. (2019). Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. nameOfConference DOI: 10.1016/j.ygyno.2019.04.679 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58607 Cohen P, Powell A, Böhm S et al. (2019). Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data. nameOfConference DOI: 10.1016/j.ygyno.2019.04.679 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65809 Crosbie E, MANCHANDA R, Manchester International Consensus Group (2019). The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. nameOfConference DOI: 10.1038/s41436-019-0489-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56622 GABA F, Piek J, Menon U et al. (2019). Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary. nameOfConference DOI: 10.1111/1471-0528.15651 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55319 MANCHANDA R, GABA F (2019). A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm. nameOfConference DOI: 10.1111/1471-0528.15657 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55616 Koutoukidis D, Beeken R, MANCHANDA R et al. (2019). Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial. nameOfConference DOI: 10.1136/ijgc-2018-000039 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/49823 MANCHANDA R, Matthew B, GABA F et al. (2019). Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study. nameOfConference DOI: 10.1111/1471-0528.15654 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55771 Osman M, Chandrasekaran D, Musa E et al. (2018). Evaluation of the diagnostic hysteroscopy service in gynaecology oncology. National Trainees Conference 2018 DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56070 MANCHANDA R, GABA F (2018). Population Based Testing for Primary Prevention: A Systematic Review. nameOfConference DOI: 10.3390/cancers10110424 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51824 Puntambekar S, MANCHANDA R (2018). Surgical pelvic anatomy in gynecologic oncology.. nameOfConference DOI: 10.1002/ijgo.12616 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/47924 Manchanda R, Gaba F (2018). Population Based Testing for Primary Prevention: A Systematic Review. nameOfConference DOI: 10.20944/preprints201809.0602.v1 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/52323 MANCHANDA R, Legood R (publicationYear). Population based germline testing for primary cancer prevention. nameOfConference DOI: 10.18632/oncotarget.25995 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/45084 Jiang J, Phadnis S, Miller R et al. (2018). DISTANT RECURRENCES ARE COMMON FOLLOWING PELVIC EXENTERATION FOR MALIGNANCY OF NON-CERVICAL ORIGIN. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65572 Jiang J, Phadnis S, Miller R et al. (2018). OUTCOMES OF BOWEL RESECTIONS DURING SURGICAL CYTOREDUCTION OF ADVANCED STAGE OVARIAN CANCER: SHOULD WE BE WORKING TOWARDS REDUCING STOMA RATES?. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65786 Singh N, Piskorz A, Bosse T et al. (2018). P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69398 Sundar S, Kumar S, Long J et al. (2018). PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY. nameOfConference DOI: doi QMRO: qmroHref Farrag A, Light M, Sahdev A et al. (2018). SOLITARY RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE CERVIX IN THE OMENTUM - MANAGEMENT OF AN UNUSUAL PRESENTATION. nameOfConference DOI: doi QMRO: qmroHref Manchanda R, Blyuss O, Gaba F et al. (2018). Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. nameOfConference DOI: 10.1136/jmedgenet-2017-105195 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/38363 Yang X, Leslie G, Gentry-Maharaj A et al. (2018). Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. nameOfConference DOI: 10.1136/jmedgenet-2018-105313 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/37923 Vazquez MA, Marino IP, BLYUSS O et al. (2018). A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer. nameOfConference DOI: 10.1016/j.bspc.2018.07.001 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42483 BLYUSS O, Burnell M, Ryan A et al. (2018). Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population. nameOfConference DOI: 10.1158/1078-0432.CCR-18-0208 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42484 Manchanda R, Patel S, Gordeev VS et al. (2018). Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. nameOfConference DOI: 10.1093/jnci/djx265 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/35943 Chuang L, Berek J, Randall T et al. (2018). Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. nameOfConference DOI: 10.1016/j.gore.2018.05.005 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/41283 Mariño IP, Vázquez MA, Blyuss O et al. (2018). Diagnosis of ovarian cancer based on longitudinal measurements of multiple biomarkers. nameOfConference DOI: doi QMRO: qmroHref Crusz SM, Chandrasekaran D, Phadnis S et al. (2018). Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC).. nameOfConference DOI: 10.1200/jco.2018.36.15_suppl.e17530 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65785 Chandrasekaran D, Manchanda R (2018). Germline & somatic genetic testing in ovarian cancer patients.. nameOfConference DOI: 10.1111/1471-0528.15225 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/36592 Patel S, Legood R, Evans DG et al. (2018). Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women. nameOfConference DOI: 10.1016/j.ajog.2017.12.221 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/31164 Chandrasekaran D, Gaba F, Manchanda R (2018). Preinvasive Disease, Screening and Hereditary Cancer. nameOfConference DOI: 10.1017/9781316986844.008 QMRO: qmroHref MANCHANDA R, Menon U (2018). Setting the threshold for surgical prevention in women at increased risk of ovarian cancer. nameOfConference DOI: 10.1097/IGC.0000000000001147 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/31163 Meisel SF, Freeman M, Waller J et al. (2017). Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study. nameOfConference DOI: 10.1186/s12889-017-4889-0 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/29163 Manchanda R, Patel S, Antoniou AC et al. (2017). Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry. nameOfConference DOI: 10.1016/j.ajog.2017.06.038 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24965 Manchanda R, Gaba F, Bottla K et al. (2017). PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS). nameOfConference DOI: doi QMRO: qmroHref Koutoukidis DA, Beeken RJ, Manchanda R et al. (2017). Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial. nameOfConference DOI: 10.1136/bmjopen-2017-018015 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/30603 Gan C, Chenoy R, Chandrasekaran D et al. (2017). Persistence of fimbrial tissue on the ovarian surface after salpingectomy. nameOfConference DOI: 10.1016/j.ajog.2017.06.004 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24890 Rosenthal AN, Fraser LSM, Philpott S et al. (2017). Evidence of Stage Shift in Women Diagnosed with Ovarian Cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. nameOfConference DOI: 10.1097/01.ogx.0000520207.28837.3a QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/48284 Bansal JK, Goldrick IG, Manchanda R et al. (2017). Rapid-access gynecological oncology clinic outcomes in North London, UK. nameOfConference DOI: 10.2147/ca.s127369 QMRO: qmroHref MANCHANDA R, Legood R, Antoniou AC et al. (2017). Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer. nameOfConference DOI: 10.1111/1471-0528.14763 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24546 Rosenthal AN, Fraser LSM, Philpott S et al. (2017). Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.. nameOfConference DOI: 10.1200/JCO.2016.69.9330 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/21300 Johnston C, Ng JS, Manchanda R et al. (2017). Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges. nameOfConference DOI: 10.1016/j.gore.2017.01.003 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19546 Manchanda R (2017). Opportunistic salpingectomy for prevention of ovarian cancer. nameOfConference DOI: 10.1111/1471-0528.14655 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/23063 Gan C, Bossart M, Piek J et al. (2017). Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees.. nameOfConference DOI: 10.1097/IGC.0000000000000879 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19547 Koutoukidis DA, Beeken RJ, Manchanda R et al. (2017). Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1. nameOfConference DOI: 10.1186/s13063-017-1776-z QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19539 Gaba FM, Manchanda R, Gaba FM et al. (2017). Genetic testing for gynaecological cancer. nameOfConference DOI: 10.1016/j.ogrm.2016.11.001 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18971 Burnell M, Iyer R, Gentry-Maharaj A et al. (2016). Benchmarking of surgical complications in gynaecological oncology: Prospective multicentre study. nameOfConference DOI: 10.1111/1471-0528.13994 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12657 Pennington M, Gentry-Maharaj A, Karpinskyj C et al. (2016). Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).. nameOfConference DOI: 10.1371/journal.pone.0165539 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/17827 La Russa M, Biliatis I, Brockbank E et al. (2016). CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY. 16th biennial International Gynecologic Cancer Society (IGCS) meeting DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18943 Manchanda R, Gordeev V, Antoniou A et al. (2016). Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women. 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016) DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18946 Phadnis S, Vali S, Oram D et al. (2016). Enhanced recovery after major gynaecological oncology surgery: Are we meeting the standards?. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65625 Phadnis S, Lawrence A, Oram D et al. (2016). Morbidity and mortality following major surgery for gynaecological malignancy: A prospective observational study from a cancer centre in London. nameOfConference DOI: doi QMRO: qmroHref Kumar S, Long J, Rudge G et al. (2016). SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer. 16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24955 Phadnis S, Korompelis P, Iamprou C et al. (2016). Surgical and oncological outcome of morbidly obese (BMI > 40) women having laparoscopic surgery for early stage endometrial cancer. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65947 Manchanda R, Legood R, Antoniou AC et al. (2016). Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingooophorectomy' for ovarian cancer prevention: A cost-effectiveness analysis. nameOfConference DOI: 10.1136/jmedgenet-2016-103800 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13144 Manchanda R, Burnell M, Loggenberg K et al. (2016). Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations. nameOfConference DOI: 10.1136/jmedgenet-2015-103740 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12152 Chuang LT, Randall TC, Denny L et al. (2016). Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. nameOfConference DOI: 10.1097/IGC.0000000000000735 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/15553 Manchanda R, Cibula D (2016). Ovarian Cancer Screening There May Be Light at the End of the Tunnel?. nameOfConference DOI: 10.1097/IGC.0000000000000706 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12881 Koutoukidis DA, Beeken RJ, Manchanda R et al. (2016). Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. nameOfConference DOI: 10.1186/s13063-016-1260-1 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12157 MANCHANDA R, Menon U (2016). Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial FOR: There is lack of clarity on a number of key issues. nameOfConference DOI: 10.1111/1471-0528.13741 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11153 Manchanda R, Jacobs I (2016). Genetic screening for gynecological cancer: Where are we heading?. nameOfConference DOI: 10.2217/fon.15.278 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10784 Manchanda R, Chandrasekaran D, Saridogan E et al. (2016). Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated into Routine Care or Offered in the Context of a Clinical Trial?. nameOfConference DOI: 10.1097/IGC.0000000000000567 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10777 Blyuss KB, MANCHANDA R, Kurths J et al. (2016). Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks. nameOfConference DOI: 10.1155/2016/7904693 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11154 Dilley J, Manchanda R, Johnson M et al. (2016). Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients. nameOfConference DOI: 10.1016/j.ijgo.2015.09.013 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12243 Manchanda R, Legood R, Pearce L et al. (2015). Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. nameOfConference DOI: 10.1016/j.ygyno.2015.10.001 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10775 Manchanda R, Loggenberg K, Burnell M et al. (2015). A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/39589 Chandrasekaran D, Menon U, Evans G et al. (2015). Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. nameOfConference DOI: 10.1007/s10689-015-9823-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10800 Chandrasekaran D, Menon U, Evans G et al. (2015). Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. nameOfConference DOI: 10.1007/s10689-015-9823-y QMRO: qmroHref Iyer R, Gentry-Maharaj A, Nordin A et al. (2015). Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC - UK gynaecological oncology surgical outcomes and complications). nameOfConference DOI: 10.1038/bjc.2014.630 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12471 Jervis S, Song H, Lee A et al. (2015). A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. nameOfConference DOI: 10.1136/jmedgenet-2015-103077 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12239 Manchanda R, Legood R, Burnell M et al. (2015). Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. nameOfConference DOI: 10.1093/jnci/dju380 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11002 Manchanda R, Loggenberg K, Sanderson S et al. (2015). Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial. nameOfConference DOI: 10.1093/jnci/dju379 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12434 Piek J, Bossart M, Boor K et al. (2015). The work place educational climate in gynecological oncology fellowships across Europe the impact of accreditation. nameOfConference DOI: 10.1097/IGC.0000000000000323 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/14953 Manchanda R, Sanderson S, Loggenberg K et al. (2014). POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS.. nameOfConference DOI: doi QMRO: qmroHref Manchanda R, Legood R, Burnell M et al. (2014). POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12313 Manchanda R, Gessler S, Loggenberg K et al. (2014). Population Testing for Inherited, Cancer Predisposing BRCA 1 and BRCA2 Founder Mutations in the Ashkenazi Jewish Community in London: The Psychological Impact on Participants of a Randomised Controlled Trial. nameOfConference DOI: doi QMRO: qmroHref Philpott S, Rizzuto I, Fraser L et al. (2013). DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/45783 Manchanda R, Legood R, Burnell M et al. (2013). POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL. nameOfConference DOI: doi QMRO: qmroHref Rosenthal AN, Fraser L, Philpott S et al. (2013). RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56557 Manchanda R, Halaska MJ, Piek JM et al. (2013). The need for more workshops in laparoscopic surgery and surgical anatomy for european gynaecological oncology trainees: A survey by the european network of young gynaecological oncologists. nameOfConference DOI: 10.1097/IGC.0b013e31829703b0 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12334 Rosenthal AN, Fraser L, Philpott S et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). nameOfConference DOI: doi QMRO: qmroHref Rosenthal AN, Fraser L, Philpott S et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2).. nameOfConference DOI: 10.1200/jco.2013.31.15_suppl.5507 QMRO: qmroHref Kalsi JK, Manchanda R, Menon U (2013). Screening for gynecological cancers. nameOfConference DOI: 10.1586/eog.13.5 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13602 Rosenthal AN, Fraser L, Manchanda R et al. (2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. nameOfConference DOI: 10.1200/JCO.2011.39.7638 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13391 Manchanda R, Godfrey M, Wong-Taylor LA et al. (2013). The need for accredited training in gynaecological oncology: A report from the european network of young gynaecological oncologists (ENYGO). nameOfConference DOI: 10.1093/annonc/mds588 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12226 Manchanda R, Drapkin R, Menon U (2013). There is a need for routine peritoneal cytology at RRSO. nameOfConference DOI: 10.1016/j.ygyno.2012.09.031 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12304 Manchanda R, Saridogan E, Abdelraheim A et al. (2012). Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). nameOfConference DOI: 10.1007/s00404-012-2492-2 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12296 Fourkala EO, Gentry-Maharaj A, Burnell M et al. (2012). Histological confirmation of breast cancer registration and self-reporting in England and Wales: A cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. nameOfConference DOI: 10.1038/bjc.2012.155 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10809 Manchanda R, Silvanto A, Abdelraheim A et al. (2012). Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy. nameOfConference DOI: 10.1097/IGC.0b013e31824b4093 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12233 Menon U, Kalsi J, Jacobs I et al. (2012). International conference on ovarian cancer screening 29th-30th November 2011, Royal College of Physicians, London. nameOfConference DOI: 10.1097/IGC.0b013e3182557e41 QMRO: qmroHref Manchanda R, Burnell M, Abdelraheim A et al. (2012). Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis. nameOfConference DOI: 10.1111/j.1471-0528.2011.03257.x QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12664 Gentry-Maharaj A, Kalsi J, Burnell M et al. (2012). Screening of symptomatic women for ovarian cancer. nameOfConference DOI: 10.1016/S1470-2045(12)70120-1 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13651 Vaes E, Manchanda R, Autier P et al. (2012). Differential diagnosis of adnexal masses: Sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool. nameOfConference DOI: 10.1002/uog.9079 QMRO: qmroHref Brantnerova R, Manchanda R, Colombo N (2012). The European society of gynaecological oncology: update on objectives and educational and research activities.. nameOfConference DOI: 10.14694/EdBook_AM.2012.32.55 QMRO: qmroHref Manchanda R, Drapkin R, Jacobs I et al. (2012). The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. nameOfConference DOI: 10.1016/j.ygyno.2011.10.017 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12268 Gultekin M, Dursun P, Vranes B et al. (2011). Gynecologic oncology training systems in Europe: A report from the European network of young gynaecological oncologists. nameOfConference DOI: 10.1097/IGC.0b013e3182202d17 QMRO: qmroHref Manchanda R, Abdelraheim A, Johnson M et al. (2011). Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. nameOfConference DOI: 10.1111/j.1471-0528.2011.02920.x QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/14031 (2011). Cross-sectional imaging. nameOfConference DOI: 10.3109/9781841847658-8 QMRO: qmroHref Vaes E, Manchanda R, Nir R et al. (2011). Mathematical models to discriminate between benign and malignant adnexal masses: Potential diagnostic improvement using ovarian histoscanning. nameOfConference DOI: 10.1097/IGC.0b013e3182000528 QMRO: qmroHref Jacobs I, Gentry-Maharaj A, Burnell M et al. (2011). Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort. nameOfConference DOI: 10.1016/S1470-2045(10)70268-0 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/15120 Pichert G, Jacobs C, Jacobs I et al. (2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. nameOfConference DOI: 10.1007/s10689-010-9333-x QMRO: qmroHref Vaes E, Manchanda R, Nir R et al. (2009). 1329 A sequential use of the Risk of Malignancy Index and Ovarian HistoScanning for the differential diagnosis of adnexal masses. nameOfConference DOI: 10.1016/s1359-6349(09)70502-6 QMRO: qmroHref Manchanda R, Rosenthal A, Burnell M et al. (2009). Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers. nameOfConference DOI: 10.1136/jmg.2009.067462 QMRO: qmroHref Manchanda R, Menon U, Michaelson-Cohen R et al. (2009). Hereditary non-polyposis colorectal cancer or Lynch syndrome: The gynaecological perspective. nameOfConference DOI: 10.1097/GCO.0b013e32831c844d QMRO: qmroHref Manchanda R, Baldwin P, Crawford R et al. (2009). Is close follow up feasible for high-risk cervical premalignant lesion in developing countries? Author's reply. nameOfConference DOI: 10.1111/j.1471-0528.2008.02019.x QMRO: qmroHref Manchanda R, Jacobs IJ (2009). Screening and prevention of gynaecological cancers. nameOfConference DOI: 10.1017/CBO9780511691799.003 QMRO: qmroHref Manchanda R, Menon U (2008). Serum markers for gynaecological cancer in the reproductive years. nameOfConference DOI: 10.1017/cbo9781107786110.015 QMRO: qmroHref Manchanda R, Baldwin P, Crawford R et al. (2008). Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. nameOfConference DOI: 10.1111/j.1471-0528.2008.01853.x QMRO: qmroHref Manchanda R, Palep-Singh M, Prentice A (2008). Can uterine artery embolisation affect endometrial perfusion and function. nameOfConference DOI: 10.1080/01443610801967000 QMRO: qmroHref Manchanda R, Kriplani A (2005). Giant malignant ovarian tumor: A case report. nameOfConference DOI: 10.1111/j.1525-1438.2005.00196.x QMRO: qmroHref Manchanda R, Sriemevan A (2005). Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta. nameOfConference DOI: 10.1080/01443610500052013 QMRO: qmroHref Manchanda R, Refaie A (2005). Acute pneumoperitoneum following coitus.. nameOfConference DOI: 10.1017/s148180350001294x QMRO: qmroHref Manchanda R, Varma R, Anya I et al. (2004). Representation of authors and editors from poor countries [1] (multiple letters). nameOfConference DOI: doi QMRO: qmroHref Manchanda R, Varma R (2004). Representation of authors and editors from poor countries: observed publication bias may reflect who is funding research.. nameOfConference DOI: 10.1136/bmj.329.7457.110 QMRO: qmroHref Kriplani A, Agarwal N, Parul et al. (2003). Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis. nameOfConference DOI: 10.1046/j.1341-8076.2003.00028.x QMRO: qmroHref Kriplani A, Manchanda R, Nath J et al. (2002). A randomized trial of danazol pretreatment prior to endometrial resection. nameOfConference DOI: 10.1016/S0301-2115(02)00012-X QMRO: qmroHref Kriplani A, Manchanda R, Monga D et al. (2001). Depot medroxy progesterone acetate: A poor preparatory agent for endometrial resection. nameOfConference DOI: 10.1159/000052969 QMRO: qmroHref Kriplani A, Agarwal N, Roy KK et al. (2001). Laparoscopic management of Sertoli-Leydig cell tumors of the ovary: A report of two cases. nameOfConference DOI: doi QMRO: qmroHref Kriplani A, Manchanda R, Agarwal N et al. (2001). Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. nameOfConference DOI: 10.1016/S1074-3804(05)60613-5 QMRO: qmroHref SupervisionXia Wei: Decision Analysis and Economic Modelling for Ovarian Cancer Prevention. Funding: Rosetrees Trust and China Medical Board Samuel Oxley: Prevention of Endometrial Cancer. Funding: Rosetrees Trust Jyotsna Pundir: Role of Myo-inositol in Poly Cystic Ovary Syndrome. Funding: Self funded Dhivya Chandrasekaran: Implementation of unselected germline and somatic genetic testing in epithelial ovarian cancer delivered through a cancer-multidisciplinary pathway. Funding: Barts Charity Faiza Gaba: Targeted Prevention of Ovarian Cancer. Funding: Rosetrees Trust and Barts Charity